| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Aug―02 |
High-Priority Pathogens with Potential to Cause “Disease X” Pandemics |
Qi Shi, Xiaoping Dong |
| 2 |
[GO] |
2025―Mar―28 |
Corrigendum to: Long-Term Protection from SARS-CoV-2 Variants in Mice by a Phase II Clinically Evaluated Original mRNA Vaccine Booster |
Jun Liu, Jing Sun, Liping Luo, Yanhong Tang, Hu Guo, Yiyun He, et al. (+10) Qi Liu, Xuya Yu, Yumei Huang, Siyuan Zhang, Airu Zhu, Jun Dai, Fan Zhang, Tao Huang, Jincun Zhao, Yucai Peng |
| 3 |
[GO] |
2024―Nov―27 |
In Silico Analysis of Cross-Species Sequence Variability in Host Interferon Antiviral Pathway Proteins and SARS-CoV-2 Susceptibility |
Sally A. Mayasich, Peter G. Schumann, Maxwell Botz, Carlie A. LaLone |
| 4 |
[GO] |
2024―May―18 |
Long-Term Protection from SARS-CoV-2 Variants in Mice by a Phase II Clinically Evaluated Original mRNA Vaccine Booster |
Jun Liu, Jing Sun, Liping Luo, Yanhong Tang, Hu Guo, Yiyun He, et al. (+10) Qi Liu, Xuya Yu, Yumei Huang, Siyuan Zhang, Airu Zhu, Jun Dai, Fan Zhang, Tao Huang, Jincun Zhao, Yucai Peng |
| 5 |
[GO] |
2024―Feb―14 |
Factors Associated with the Clinical Severity and Disease Burden of COVID-19 Caused by Omicron BA.2 in Shanghai and Hong Kong, China |
Ruijia Sun, Xinhua Chen, Yanpeng Wu, Hongjie Yu |
| 6 |
[GO] |
2024―Feb―01 |
The Intra-Host Evolution of SARS-CoV-2 After Neutralizing Antibody Therapy, Revealed by Nanopore Sequencing |
Hong-Xiang Zeng, Wen-Hong Zu, Hai-Yan Wang, Jing Yuan, Lin Cheng, Gang Xu, et al. (+4) Yi-Gan Huang, Yang Liu, Shu-Ye Zhang, Zheng Zhang |
| 7 |
[GO] |
2024―Jan―10 |
Emergence and Characterization of the SARS-CoV-2 JN.1 Variant: Global Prevalence and Implications for Public Health |
Hang Fan, Si Qin, Yujun Cui |
| 8 |
[GO] |
2023―Dec―31 |
Health Consequences Among COVID-19 Convalescent Patients 30 Months Post-Infection in China |
Yu Yin, Yi Guo, Mingzhong Xiao, Qinlin Chen, Pinpin Long, Xi Wang, et al. (+14) Jingzhi Wang, Zuoyu Shao, Yutong Qiu, Yixuan Lu, Yuchan Yang, Xueqin Shi, Wei Ni, Shanshan Cheng, Qi Wang, Li Liu, Tangchun Wu, Xiaodong Li, Hao Wang, Yu Yuan |
| 9 |
[GO] |
2023―Dec―01 |
Clinical Application of SARS-CoV-2 IgM and IgG Antibody Detection Using the Colloidal Gold Immunochromatography Assay |
Lipeng Liu, Kangping Zhou, Yan Xing, Wei Luo, Bing Pei, Junqiang Xu, et al. (+7) Lei Yi, Honglei Wang, Juan Wang, Wei Zhang, Fei Yu, Kun Cai, Peng Liu |
| 10 |
[GO] |
2023―Nov―17 |
Pandemic COVID-19 and Endemic Neglected Tropical Diseases: Friends or Foes? |
Mehdi Borhani Zarandi, Xuemin Jin, Saeid Fathi, Majid Fasihi Harandi, Sami Simsek, Mohammad Mehdi Ommati, et al. (+2) Mingyuan Liu, Jing Ding |
| 11 |
[GO] |
2023―Apr―21 |
Co-circulation, Co-infection of SARS-CoV-2 and Influenza Virus, Where Will it Go? |
Shuai-xing Wang, Da-yan Wang |
| 12 |
[GO] |
2023―Apr―19 |
Next-Generation Vaccines against COVID-19 Variants: Beyond the Spike Protein |
Srinivasa Reddy Bonam, Haitao Hu |
| 13 |
[GO] |
2022―Sep―21 |
Evidence of the Efficacy and the Effectiveness of First Generation COVID-19 Vaccines in Clinical Trials and Real-world Studies |
Jingxin Li, Zhuopei Li, Yawen Zhu, Li Zhou, Fengcai Zhu |
| 14 |
[GO] |
2022―Sep―06 |
Effectiveness of Inactivated SARS-CoV-2 Vaccines During a Delta Variant Outbreak in Hunan Province, China: A Retrospective Cohort Study |
Xuemei Yan, Zhihui Dai, Qianhui Wu, Xiaolei Wang, Yan Wang, Ge Zeng, et al. (+5) Yanpeng Wu, Shengbao Chen, Lan Yi, Hongjie Yu, Lidong Gao |
| 15 |
[GO] |
2022―Apr―01 |
The Animal Origin of Major Human Infectious Diseases: What Can Past Epidemics Teach Us About Preventing the Next Pandemic? |
Guha Dharmarajan, Ruiyun Li, Emmanuel Chanda, Katharine R. Dean, Rodolfo Dirzo, Kjetill S. Jakobsen, et al. (+6) Imroze Khan, Herwig Leirs, Zheng-Li Shi, Nathan D. Wolfe, Ruifu Yang, Nils Chr. Stenseth |
| 16 |
[GO] |
2022―Feb―08 |
SARS-CoV-2 Variants and Vaccination |
Yang Liu, Jianying Liu, Pei-Yong Shi |
| 17 |
[GO] |
2022―Jan―25 |
Isothermal Amplification Technology for Diagnosis of COVID-19: Current Status and Future Prospects |
Xuejun Ma |
| 18 |
[GO] |
2022―Jan―06 |
Online Education in Human Parasitology during the COVID-19 Pandemic in Wuhan: Our Experiences, Challenges, and Perspectives |
Jiahui Lei, Fei Guan, Honggang Zhu, Wenqi Liu |
| 19 |
[GO] |
2021―Dec―03 |
Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) |
Si Qin, Mengnan Cui, Siqi Sun, Jiyang Zhou, Zongmin Du, Yujun Cui, Hang Fan |
| 20 |
[GO] |
2021―Sep―15 |
Variants of SARS Coronavirus-2 and Their Potential Impact on the Future of the COVID-19 Pandemic |
Xin Li, Kelvin Kai-Wang To, Kwok-Yung Yuen |
| 21 |
[GO] |
2021―Sep―04 |
Analysis of Intermediate Hosts and Susceptible Animals of SARS-CoV-2 by Computational Methods |
Yueying Yang, Mengzhu Zheng, Yang Liu, Yali Wang, Yang Xu, Yirong Zhou, et al. (+3) Dejuan Sun, Lixia Chen, Hua Li |
| 22 |
[GO] |
2021―Aug―31 |
SARS-CoV-2 Lambda Variant: Spatiotemporal Distribution and Potential Public Health Impact |
Cao Chen, Qi Shi, Xiao-Ping Dong |
| 23 |
[GO] |
2021―Aug―26 |
Dynamic Changes in Chest CT Images Over 167 Days in 11 Patients with COVID-19: A Case Series and Literature Review |
Jianqin Liang, Guizeng Liu, Shuzhuang Yu, Yang Yang, Yanchun Li, Hongli Tian, et al. (+2) Zhe Chen, Wenping Gong |
| 24 |
[GO] |
2021―Aug―17 |
Rapid Global Spread of the SARS-CoV-2 Delta (B.1.617.2) Variant: Spatiotemporal Variation and Public Health Impact |
Qi Shi, Xiao-Ping Dong |